BON

3 - Bon Natural Life Ltd (0001816815) (Issuer)

3 - Bon Natural Life Ltd (0001816815) (Issuer)

3 - Bon Natural Life Ltd (0001816815) (Issuer)

3 - Bon Natural Life Ltd (0001816815) (Issuer)

3 - Bon Natural Life Ltd (0001816815) (Issuer)

3 - Bon Natural Life Ltd (0001816815) (Issuer)

3 - Bon Natural Life Ltd (0001816815) (Issuer)

XI'AN, China, March 31, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agreement (the "Agreement") with Tigerbone Group Limited ("Tigerbone Group").  As part of this strategic initiative, the parties also announced plans to establish the "BON Cooperation and Development Committee," which will serve as a central platform to advance collaboration in traditional Chinese medicine and life sciences through resource sharing and complementary strengths. Pursuant to the Agreement, an

6-K - Bon Natural Life Ltd (0001816815) (Filer)

XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful development of a premium anti-aging facial mask incorporating apple polyphenols as its core active ingredient and integrated with AI-enabled flexible bio-electronic technology. Leveraging advanced transdermal delivery systems, this product integrates plant-derived active ingredients with intelligent flexible electronics, creating a next-generation skin care solution designed to be non-invasive, painless, and suitable for at-home use. Serving as the core na

6-K - Bon Natural Life Ltd (0001816815) (Filer)

XI'AN, China, Feb. 17, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, today announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-Manufacturing (the "Joint Laboratory"). The Joint Laboratory was inaugurated on December 18, 2025 through a collaboration between the Company's domestic operating subsidiary, Xi'an App-Chem Bio-Tech Co., Ltd., and Shaanxi Chang'an Pilot Life Science Industry Innovation Center Co., Ltd. ("Chang'an Pilot"). The Joint Laboratory will focus on the research and development of bio-manufactured natural activ

6-K - Bon Natural Life Ltd (0001816815) (Filer)

XI'AN, China, Dec. 10, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of a new health-focused kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry Co., Ltd. ("Qingshengyuan"), a leading distributor of functional health products in China focusing on digestive and metabolic wellness. The two parties entered into a non-exclusive strategic sales agreement. The term of the agreement is 24 months with a total contract value of $12 million. Pursuant to the agreement, Qingshengyuan will sell and di

XI'AN, China, Nov. 25, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 36 months with a total contract value of US$26 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generation tea pigment-based digestive health products in Greater China. Tea pigments, a key bioactive complex derived from tea, possess a strong scientific profile

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

F-3/A - Bon Natural Life Ltd (0001816815) (Filer)

F-3 - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

XI'AN, China, Sept. 9, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced it has entered into a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 24 months with a total contract value of US$18 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's innovative second-generation Apple Series health products across Greater China, tapping into significant market potential in the weight management and m

XI'AN, China, Sept. 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform. Preliminary tests demonstrate that these compounds exhibit significant activity in weight management, with key efficacy indicators outperforming current mainstream weight-managing drugs, injecting new momentum into global R&D of weight-managing drugs. With a worsening global obesity crisis, the weight-manag

XI'AN, China, Aug. 5, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC. As previously reported on a Form 6-K filed with the U.S. Securities and Exchange Commission on July 11, 2025, Bon Natural Life Limited ( "the Company") received notification from the Nasdaq Hearings Panel (the "Panel") that the Company had regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule"). The Panel also advised the Company that it will be subject to a one-year Discretionary Panel M

6-K - Bon Natural Life Ltd (0001816815) (Filer)